Fate Therapeutics Inc (NASDAQ:FATE)

10.82
Delayed Data
As of Jul 20
 -0.26 / -2.35%
Today’s Change
2.52
Today|||52-Week Range
14.45
+77.09%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close11.08
Today’s open11.11
Day’s range10.80 - 11.37
Volume308,122
Average volume (3 months)596,252
Market cap$571.9M
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+2.86%
Earnings growth (this year)-5.07%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.72%
P/E ratioNM
Price/Sales62.47
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc-0.11-3.89%
CGENCompugen Ltd-0.13-3.57%
VBLTVascular Biogenics L...0.000.00%
KMDAKamada Ltd0.000.00%
Data as of 4:00pm ET, 07/20/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$4.1M
Annual profit (last year)-$43.0M
Net profit margin-1,046.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts